BrainStorm Cell Therapeutics
BCLI
#10281
Rank
โ‚ฌ7.18 M
Marketcap
0,65ย โ‚ฌ
Share price
0.00%
Change (1 day)
-54.87%
Change (1 year)

Revenue for BrainStorm Cell Therapeutics (BCLI)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BrainStorm Cell Therapeutics from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
โ‚ฌ8.73 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ25.24 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ1.99 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ75.68 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ92.7 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚ฌ97.85 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA